Antibody response to the BNT162b2 SARS-CoV-2 vaccine in paediatric patients with inflammatory bowel disease treated with anti-TNF therapy
Zahra Shire, Frederic Reicherz, Sally Lawrence, Harjeev Sudan, Liam Golding, Abdelilah Majdoubi, Paul N. Levett, Pascal M. Lavoie, Kevan Jacobson
Topics & Concepts
MedicineInflammatory bowel diseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Inflammatory Bowel DiseasesCoronavirus disease 2019 (COVID-19)ImmunologyAntibody2019-20 coronavirus outbreakTumor necrosis factor alphaAntibody responseDiseaseVirologyInternal medicineInfectious disease (medical specialty)OutbreakSARS-CoV-2 and COVID-19 ResearchImmunodeficiency and Autoimmune DisordersT-cell and B-cell Immunology